Use of riluzole prodrugs to treat Alzheimer's disease
US12201618B2 · kind B2 · utility
0Cited by
4References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 18, 2021 |
| Grant date | Jan 21, 2025 |
| Priority date | — |
| Expiry date | Mar 30, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2054
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods of treating Alzheimer's Disease by administering to a patient in need thereof a riluzole prodrug such as troriluzole. Pharmaceutical compositions and kits including the riluzole prodrugs are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.